What is the appropriate treatment protocol for a dengue patient admitted to the ward?

Dengue Ward Treatment Protocol

For dengue patients admitted to the ward, the cornerstone of management is judicious intravenous fluid resuscitation guided by clinical assessment of plasma leakage and perfusion status, with crystalloids as first-line therapy and strict avoidance of unnecessary platelet transfusions. 1

Initial Assessment and Risk Stratification

Upon ward admission, immediately classify patients into risk categories based on:

• Warning signs of plasma leakage: Abdominal pain, persistent vomiting, clinical fluid accumulation (ascites, pleural effusion), mucosal bleeding, lethargy/restlessness, liver enlargement >2cm, rising hematocrit with rapid platelet decline 1, 2
• Vital signs: Focus on pulse pressure (narrowing <20mmHg indicates shock), capillary refill time, peripheral perfusion, mental status 3
• Laboratory monitoring: Serial hematocrit (every 12-24 hours), platelet count, liver enzymes, albumin if available 4

Fluid Management Strategy

For Patients WITHOUT Warning Signs (Mild Dengue)

• Oral rehydration with maintenance fluids
• Monitor as outpatient or short observation
• Daily hematocrit and platelet monitoring

For Patients WITH Warning Signs or Plasma Leakage

Crystalloid solutions are the first-line fluid for all dengue patients 3. The evidence shows no superiority of colloids over crystalloids in most dengue cases, and crystalloids are more suitable given lower cost and fewer complications 3.

Initial fluid resuscitation protocol:

• Start with crystalloid bolus 10-20 mL/kg over 1-2 hours 3
• Reassess perfusion status after each bolus using clinical indicators: capillary refill time, skin temperature, peripheral pulses, mental status, urine output (target >0.5 mL/kg/hour in adults, >1 mL/kg/hour in children) 3
• Continue liberal fluid administration for 24-48 hours during the critical phase 3

Important caveat: While aggressive fluid resuscitation is essential, avoid fluid overload which can precipitate pulmonary edema and worsen outcomes 5. Titrate fluids based on clinical response, not fixed protocols.

For Severe Dengue Shock Syndrome

In children with severe dengue shock (pulse pressure <10mmHg), colloid solutions may be beneficial 3. However, for moderate shock (pulse pressure 10-20mmHg), crystalloids and colloids show similar outcomes, making crystalloids the practical first choice 3.

If tissue hypoperfusion persists despite liberal fluid resuscitation:

• Add dopamine or epinephrine (adrenaline) as vasopressor support 3
• Monitor blood pressure and heart rate frequently 3
• Consider hydrocortisone up to 300mg/day (or prednisolone 75mg/day) in adults requiring escalating vasopressor doses 3

Blood Product Transfusion Guidelines

Platelet transfusion is NOT indicated based on platelet count alone. Studies demonstrate significant reduction in unnecessary platelet transfusions (from 21.7% to 5.2%) improves outcomes 4.

Transfuse platelets only when:

• Active bleeding with thrombocytopenia
• Invasive procedures required with platelet count <20,000/μL

Blood transfusion indicated when:

• Hemoglobin <4 g/dL, OR
• Hemoglobin <6 g/dL with signs of heart failure (dyspnea, hepatomegaly, gallop rhythm) 5

Monitoring During Critical Phase (Days 3-7)

• Hematocrit: Every 12-24 hours to detect hemoconcentration (rising hematocrit indicates plasma leakage) 4
• Vital signs: Every 4-6 hours minimum, focusing on pulse pressure narrowing
• Urine output: Hourly if shocked, otherwise every 4-6 hours
• Clinical perfusion markers: Capillary refill, extremity temperature, mental status 3
• Fluid balance: Strict input/output monitoring

Supportive Care

• Antipyretics: Paracetamol (acetaminophen) only; avoid NSAIDs and aspirin due to bleeding risk 5
• Oxygen therapy: Target oxygen saturation >90% 3
• Position: Semi-recumbent (head elevated 30-45°) 3
• No antibiotics unless secondary bacterial infection confirmed 6
• No steroids - contraindicated in dengue management 5

Discharge Criteria

Patients may be discharged when ALL of the following are met:

• Afebrile for 24-48 hours without antipyretics
• Clinical improvement with stable vital signs
• Adequate oral intake maintained
• Urine output normal
• Hematocrit stable
• Platelet count rising (>50,000/μL preferred)
• No respiratory distress
• At least 48 hours after recovery from shock 4

Common Pitfalls to Avoid

1. Over-resuscitation: More dangerous than under-resuscitation once shock is corrected; leads to pulmonary edema and prolonged hospitalization 5
2. Prophylactic platelet transfusion: Wastes resources and increases complications without improving outcomes 4, 6
3. Delayed recognition of shock: Hypotension is a LATE sign; assess peripheral perfusion early 3
4. Inadequate monitoring during critical phase: The transition from febrile to critical phase (days 3-7) requires intensified surveillance 2
5. Premature discharge: Ensure patient is past the critical phase before discharge 4

The quality of dengue care improves dramatically when patients are cohorted under dedicated trained teams rather than distributed across multiple wards, with studies showing reduced ICU admissions (5.8% to 2.5%), shorter hospital stays (4 to 3 days), and better adherence to evidence-based protocols 4, 6.